Endocrine Abstracts

Background: The Israeli-Georgian Program Diabetes in Pregnancy was initiated at the Georgian Diabetes Center in 1997, with the aim to provide care for women with diabetes. The Program has become possible as a result of Twinning between Union of Diabetes and Endocrine Association and Israeli Diabetes Association. It was initiated in 1997, and since then it successfully works, being the longest and most sustainable Twinning program in Europe. The aim to assess the efficacy of tr...

Obesity is a major health problem commonly associated with severe comorbidities, including insulin resistance and type 2 diabetes mellitus (T2DM). Emerging evidence suggests that production and secretion of certain micro RNAs (miRNAs) are dysregulated under adverse metabolic conditions and might exert a key role in the development and progression of different metabolic-related pathologies. However, the alteration of the plasma miRNA profile under obesity condition and its path...

Follistatin is a hepatokine found to be elevated in patients with type 2 diabetes (T2D) and promotes hyperglycemia in mice. We report that elevated baseline circulating follistatin levels predict future T2D incidence in longitudinal cohorts including up to 5274 individuals. Individuals with elevated circulating follistatin had higher risk of developing type 2 diabetes during follow-up of 4 years (IMI-DIRECT-METSIM, n = 1079, Finland), 5 and 19 years (MDC-CC, n...

New evidence indicated that miRNAs may contribute to the regulation of energy balance and metabolic homeostasis, by controlling a wide range of metabolic pathways. miR-143 and miR-34a are the best studied among the miRNAs linked to adipose tissue regulation. Dietary intake, among many other environmental factors, is a key player that can induce epigenetic changes. The aim of the study was to investigate the association of the miR-143 and miR-34a expression in visceral and subc...

Background: Variations in gut microbiota might impact metabolic functions like caloric intake and energy expenditure leading to body weight excess. Microbiota modulation may be a potential approach for obesity management, especially in subject characterized by specific microbial enterotypes.Objective: We aimed to assess the impact of probiotic treatment in obese children and adolescents, under diet control, on weight loss, glucose, and insulin homeostasi...

Glucocorticoids (GC) are commonly prescribed, but their use is associated with significant adverse metabolic and bone effects. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active GC within tissues, tightly controlling the availability of GC to bind and activate the GC receptor; Our preclinical data have shown that 11β-HSD1 knock out mice resist the adverse effects of exogenous GC excess. We have now conducted a randomized, double-blind, placebo...

Introduction: Familial Partial Lipodystrophies (FPLD) are rare genetic disorders characterized by marked loss of subcutaneous fat from the extremities with variable fat loss from the face and trunk. Patients with FPLD develop metabolic abnormalities including hypertriglyceridemia, insulin resistance, and diabetes mellitus, which are difficult to manage with conventional therapies including fibrates, statins and insulin. The BROADEN study evaluated the efficacy a...